Invention Grant
- Patent Title: Method and system to provide personalized pharmaceutical compositions and dosages
- Patent Title (中): 提供个性化药物组合物和剂量的方法和系统
-
Application No.: US13754855Application Date: 2013-01-30
-
Publication No.: US08999721B2Publication Date: 2015-04-07
- Inventor: Jerome J. Schentag , Joseph M. Fayad , Scott V. Monte
- Applicant: TheraSyn Sensors, Inc.
- Applicant Address: US NY Eggertsville
- Assignee: Therabrake, Inc.
- Current Assignee: Therabrake, Inc.
- Current Assignee Address: US NY Eggertsville
- Agency: Hodgson Russ LLP
- Main IPC: G01N33/66
- IPC: G01N33/66 ; A61K31/7004 ; G06F19/00

Abstract:
Provided is a method for assessing cardiovascular risk in Metabolic Syndrome and Type 2 Diabetes patients. The method involves obtaining data from a Type 2 diabetes patient or a Metabolic Syndrome patient and determining a Fayad/Schentag index which includes a Glucose Supply Index (S) to an Insulin Demand Index (D) ratio. The Fayad/Schentag index is used in scoring cardiovascular risks of Metabolic Syndrome patients and for recommending and implementing therapeutic interventions that can be shown to lower cardiovascular risk.
Public/Granted literature
- US20140037739A1 Method and System to Provide Personalized Pharmaceutical Compositions and Dosages Public/Granted day:2014-02-06
Information query
IPC分类: